How to find low-competition generic drug opportunities

Listen to this article
Copyright © DrugPatentWatch. Originally published at
crop nurse demonstrating small double colored pill
Photo by Artem Podrez on

To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or being the first-to-market after patent expiry. Here are some detailed strategies and key performance indicators (KPIs) based on the search results:

Target Small Patient Population Drugs

Over 500 brand drugs lack generic competition, often because they treat rare diseases with small patient populations, making them less lucrative targets for generic manufacturers[3][4].


  • Analyze disease prevalence data to identify drugs treating rare conditions
  • Prioritize drugs with high pricing power due to lack of alternatives
  • Consider drugs that are difficult to manufacture economically at large scale


  • Number of patients treated
  • Revenue potential based on pricing and market size
  • Manufacturing costs and minimum viable scale

Develop Complex Formulations/Delivery Systems

Drugs with complex delivery methods like injectables, inhalers, or specialized formulations have traditionally faced less generic competition[5]. The FDA is now facilitating entry of “complex drug” generics[1].


  • Invest in R&D capabilities for complex formulations/delivery systems
  • Leverage specialized chemistry or manufacturing expertise[1][5]
  • Target newly off-patent complex drugs as first generic entrant[4]


  • Time-to-market as first generic competitor
  • Manufacturing capabilities for complex products
  • Projected market share capture as first mover

Pursue Long-Term Supply Contracts

Establishing long-term supply contracts with drug distributors can provide demand predictability and incentivize market entry/retention for generic manufacturers[2].


  • Negotiate long-term contracts with major drug distributors
  • Leverage contracts to reactivate dormant generic approvals
  • Utilize tax incentives for long-term generic supply commitments[2]


  • Value and duration of supply contracts secured
  • Number of contracted distribution channels
  • Utilization of tax incentives for supply commitments

By focusing on drugs with small patient populations, complex formulations, being first-to-market, and securing long-term supply contracts, generic manufacturers can identify and capitalize on lower competition opportunities[1][2][3][4][5].


Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top